ACTIVE

Apotheek Yves Tarnaud

Financial year 2025 · Closed on 31/12/2025

Net result152,3 k €-15,9 %over 1 year
Gross margin204,7 k €-16,5 %over 1 year
Equity24,7 k €-82,7 %over 1 year

Identity

Source · BCE/KBO

Apotheek Yves Tarnaud is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0859.602.023
Incorporation
10/07/2003
Legal form
Private limited company
Registered office
De Gryspeerstraat 19
2100 Antwerpen · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 12 financial years

20252024202320222021
Income statement
Gross margin204,7 k €245,1 k €222,3 k €181,9 k €168,9 k €
EBITDA200,4 k €240,9 k €217,2 k €178,2 k €165,2 k €
Operating result195 k €235,9 k €210,9 k €167,6 k €154,9 k €
Net result152,3 k €181,1 k €163,3 k €129,5 k €119,4 k €
Balance sheet
Equity24,7 k €142,9 k €263,4 k €352,2 k €429,5 k €
Total assets338,4 k €488,4 k €566,5 k €622,3 k €707,1 k €
Cash182,6 k €187,1 k €309,5 k €370,7 k €568,8 k €
Debts312,7 k €344 k €296,8 k €261,3 k €271,9 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

Veerle Wolfs

Bestuurder

Active
Yves Tarnaud

Bestuurder

Active

Ended mandates

Veerle Wolfs

Director

Ended
Veerle Wolfs

Manager

Ended
Yves Tarnaud

Director

Ended
Yves Tarnaud

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date12/06/202627/06/202505/07/202426/06/202313/06/202220/07/2021
General meeting28/05/202630/05/202530/05/202425/05/202327/05/202227/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202528/05/202612/06/2026DutchPDF
Abridged model31/12/202430/05/202527/06/2025DutchPDF
Abridged model31/12/202330/05/202405/07/2024DutchPDF
Abridged model31/12/202225/05/202326/06/2023DutchPDF
Abridged model31/12/202127/05/202213/06/2022DutchPDF
Abridged model31/12/202027/05/202120/07/2021DutchPDF
Abridged model31/12/201928/05/202007/07/2020DutchPDF
Abridged model31/12/201831/05/201903/07/2019DutchPDF
Abridged model31/12/201731/05/201819/07/2018DutchPDF
Abridged model31/12/201626/05/201706/07/2017DutchPDF
Abridged model31/12/201526/05/201619/07/2016DutchPDF
Abridged model31/12/201428/05/201503/08/2015DutchPDF
Abridged model31/12/201330/05/201415/07/2014DutchPDF
Abridged model31/12/201230/05/201302/07/2013DutchPDF
Abridged model31/12/201131/05/201226/07/2012DutchPDF
Abridged model31/12/201026/05/201113/07/2011DutchPDF
Abridged model31/12/200927/05/201021/06/2010DutchPDF
Abridged model31/12/200828/05/200919/08/2009DutchPDF
Abridged model31/12/200729/05/200816/06/2008DutchPDF
Abridged model31/12/200631/05/200718/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

Veerle Wolfs

Bestuurder

Active
Yves Tarnaud

Bestuurder

Active

Ended mandates

Veerle Wolfs

Director

Ended
Veerle Wolfs

Manager

Ended
Yves Tarnaud

Director

Ended
Yves Tarnaud

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates30/05/2022
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares08/12/2017
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares05/12/2013
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other30/01/2004
    DIVERSEN
    PDF
  • Mandates02/10/2003
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other17/07/2003
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025152,3 k €↓
  2. 2024
    Annual accounts 2024181,1 k €↑
  3. 2023
    Annual accounts 2023163,3 k €↑
  4. 2022
    Annual accounts 2022129,5 k €↑
  5. 2021
    Annual accounts 2021119,4 k €↑
  6. 2012
    Annual accounts 2012108,1 k €↑
  7. 2011
    Annual accounts 201174,6 k €↑
  8. 2010
    Annual accounts 201054,9 k €↓
  9. 2009
    Annual accounts 200960,2 k €↑
  10. 2008
    Annual accounts 200840,1 k €↑
  11. 2007
    Annual accounts 200717,8 k €↓
  12. 2006
    Annual accounts 200637,7 k €
  13. 10/07/2003
    IncorporationPrivate limited company